Aripiprazole and brexpiprazole: Impulsive or compulsive urges and behavior

On February 9, 2018, the FDA added the warning and instructions below to the approved drug label for brexpiprazole (brand name Rexulti). The Prescribing Information for aripiprazole (brand name Abilify) has carried the exact same warning since 2016. The third dopamine partial agonist, cariprazine (brand name Vraylar) does not carry this warning as of February…